SG11201702623TA - Boronic acid derivatives - Google Patents

Boronic acid derivatives

Info

Publication number
SG11201702623TA
SG11201702623TA SG11201702623TA SG11201702623TA SG11201702623TA SG 11201702623T A SG11201702623T A SG 11201702623TA SG 11201702623T A SG11201702623T A SG 11201702623TA SG 11201702623T A SG11201702623T A SG 11201702623TA SG 11201702623T A SG11201702623T A SG 11201702623TA
Authority
SG
Singapore
Prior art keywords
acid derivatives
boronic acid
boronic
derivatives
acid
Prior art date
Application number
SG11201702623TA
Other languages
English (en)
Inventor
Markus Klein
Oliver Schadt
Philipp Haselmayer
Michael Busch
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SG11201702623TA publication Critical patent/SG11201702623TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201702623TA 2014-10-01 2015-10-01 Boronic acid derivatives SG11201702623TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14003392 2014-10-01
PCT/EP2015/002008 WO2016050359A1 (en) 2014-10-01 2015-10-01 Boronic acid derivatives

Publications (1)

Publication Number Publication Date
SG11201702623TA true SG11201702623TA (en) 2017-04-27

Family

ID=51690789

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702623TA SG11201702623TA (en) 2014-10-01 2015-10-01 Boronic acid derivatives

Country Status (14)

Country Link
US (1) US10294246B2 (https=)
EP (1) EP3201207B1 (https=)
JP (1) JP6835711B2 (https=)
KR (1) KR102450583B1 (https=)
CN (1) CN107001390B (https=)
AU (1) AU2015327346B2 (https=)
BR (1) BR112017006420A2 (https=)
CA (1) CA2963205A1 (https=)
ES (1) ES2873000T3 (https=)
IL (1) IL251301B (https=)
MX (1) MX370336B (https=)
RU (1) RU2017115188A (https=)
SG (1) SG11201702623TA (https=)
WO (1) WO2016050359A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017115191A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты
JP6662865B2 (ja) 2014-10-01 2020-03-11 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ボロン酸誘導体
RU2017115193A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты
PL3672977T3 (pl) 2017-08-24 2022-09-26 Merck Patent Gmbh Pochodne kwasu boronowego
SG11202100727VA (en) 2018-07-26 2021-02-25 Merck Patent Gmbh Boronic acid derivatives
CN113135944A (zh) * 2020-01-19 2021-07-20 首药控股(北京)有限公司 硼酸衍生物
CN113135943A (zh) * 2020-01-19 2021-07-20 首药控股(北京)有限公司 硼酸衍生物
US20250340577A1 (en) * 2021-03-02 2025-11-06 Case Western Reserve University Beta-lactomase inhibitors and uses thereof
JP2024518834A (ja) * 2021-05-19 2024-05-07 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 雑草防除方法
WO2023006863A1 (en) 2021-07-29 2023-02-02 Merck Patent Gmbh Novel crystalline forms of [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7- oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid, adducts thereof, and processes to obtain
CN118119630A (zh) * 2021-10-14 2024-05-31 首药控股(北京)股份有限公司 硼酸衍生物
WO2023232830A1 (en) 2022-06-02 2023-12-07 Merck Patent Gmbh Boronic acid adducts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111175A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
WO2001002424A2 (en) 1999-07-07 2001-01-11 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
US7271186B1 (en) * 2002-12-09 2007-09-18 Northwestern University Nanomolar β-lactamase inhibitors
CA2705393A1 (en) * 2007-11-13 2009-05-22 Protez Pharmaceuticals, Inc. Beta-lactamase inhibitors
AR075090A1 (es) * 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
SG11201403254QA (en) * 2011-12-22 2014-07-30 Ares Trading Sa Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
RU2017115191A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты
JP6662865B2 (ja) 2014-10-01 2020-03-11 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ボロン酸誘導体
RU2017115193A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты

Also Published As

Publication number Publication date
MX370336B (es) 2019-12-10
US20180105539A1 (en) 2018-04-19
IL251301B (en) 2022-02-01
JP2017536335A (ja) 2017-12-07
KR20170062517A (ko) 2017-06-07
WO2016050359A1 (en) 2016-04-07
EP3201207B1 (en) 2021-02-24
CN107001390B (zh) 2020-11-27
KR102450583B1 (ko) 2022-10-04
CN107001390A (zh) 2017-08-01
BR112017006420A2 (pt) 2017-12-19
AU2015327346B2 (en) 2019-12-05
ES2873000T3 (es) 2021-11-03
EP3201207A1 (en) 2017-08-09
RU2017115188A (ru) 2018-11-06
MX2017004046A (es) 2017-06-19
CA2963205A1 (en) 2016-04-07
RU2017115188A3 (https=) 2019-03-29
AU2015327346A1 (en) 2017-05-18
US10294246B2 (en) 2019-05-21
JP6835711B2 (ja) 2021-02-24
IL251301A0 (en) 2017-05-29

Similar Documents

Publication Publication Date Title
ZA201703007B (en) Boronic acid derivatives
SG11201702625PA (en) Boronic acid derivatives
GB201419865D0 (en) Solution
GB201517022D0 (en) No details
GB201410907D0 (en) No details
AP2016009371A0 (en) Benzimidazol-2-amines as midh1 inhibitors
GB201519531D0 (en) No details
SG11201702620SA (en) Boronic acid derivatives
GB201517404D0 (en) No details
GB201418217D0 (en) No details
SG11201702623TA (en) Boronic acid derivatives
GB201418216D0 (en) No details
SG11201610831PA (en) Lithium-sulphur battery
SG11201609205WA (en) Heterocyclyl-butanamide derivatives
PL3164393T3 (pl) Pochodne flawaglin
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
GB201516796D0 (en) No details
GB201517412D0 (en) No details
GB201517574D0 (en) No details
IL248773A0 (en) History of naphthyridinedione
DK3200779T3 (en) Novel anthranilic acid derivatives
PL3672977T3 (pl) Pochodne kwasu boronowego
SG11201608634RA (en) Cycloalkyl-linked diheterocycle derivatives
HUE044703T2 (hu) Új CYP-eikozanoid származékok
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu